This session will focus on recent discoveries in the field of inflammation and host-pathogen response in cystic fibrosis. Researchers will present results from studies including several different types of leukocytes, effects of CFTR impairment and modulator drugs, and promising candidate biomarkers and therapeutics.
Examine the role of macrophage variability in the degree of regional airway damage within the CF lung.
Assess the impact of CFTR modulator drugs on leukocyte function.
Illustrate altered lymphocyte function in CF patients during acute pulmonary exacerbation of lung disease.